EMCELL CLINIC

Following successful animal trials started in the 1970’s by a group of young scientists at the National Medical University, in 1985, EmCell founders started working with fetal stem cells and later applying them in clinical practice. They were prompted by the experimental work with animals that had proved positive impact of stem cells harvested from animal fetuses on neurodystrophy in denervated organs and tissues. In 1987, stem cells were applied by EmCell founders, for the first time, for the treatment of cytostatic myelodepression and aplastic anemia in the National Medical University of Ukraine.

In 1991, after obtaining the permission of the Ukrainian Health Ministry, fetal stem cells started to be widely used for different diseases and conditions such as dystrophy, diseases causing cell deficit, sclerosis, and malignant processes. A group of doctors developed and introduced a reliable and safe method of fetal stem cell treatment that proved effective for certain diseases and conditions and showed good results in different patients. At the same time, no side effects or complications were reported, which allowed for the extension of the range of diseases in which stem cell therapy could be applied.

EmCell was the first clinic to develop stem cell treatment protocols for such diseases as multiple sclerosis, diabetes, and autism.

Over the years, EmCell has performed thousands of fetal stem cells treatments. Cell therapy helped to prolong life and improve life quality to thousands of patients including those suffering from the incurable diseases who lost any hope for recovery. All fetal stem cell treatment methods used at EmCell are patent-protected in different countries. EmCell was the first in the world to obtain patents for clinical application of fetal stem cell suspensions: first patent application dates back to October 18, 1993. The clinic`s patents cover methods of hematopoietic stem cell harvesting, creation of cell suspensions, treatment of autism, multiple sclerosis, diabetes mellitus, aplastic anemia, psoriasis, cancer, etc.

Starting from 1994, EmCell operated under a general license for medical practice. In 2011, a new regulation required all clinics working with stem cells to apply for a special license, the only one allowing legal manipulations with stem cells. EmCell was also the first in Ukraine to receive the state license for fetal cell bank operation.

During the years of intensive work, the EmCell team won international acclaim in the field of research and clinical application of fetal stem cells. EmCell professionals authored more than 300 scientific works published in the national as well as international magazines and congress proceedings. More than 40 articles are published in peer-reviewed journals. 

Today, EmCell consists of a Clinical Department and a laboratory complex.

PROGRAMS

Deva clinique provides access to stem cell therapy for patients suffering from degenerative and autoimmune disorders or for rejuvenation and revitalization of the body. A treatment plan for each case is created individually. To find out your plan and cost of treatment, leave your contact details, diagnosis and description of symptoms.

Below we have described several basic treatment programs.

Jacob D.

Feedback of the patient F.T.G. after stem cell treatment

Patient: F.T.G.
Gender: Male
Age: 47
Country: Italy
Diagnosis: Amyotrophic lateral sclerosis, cervical form, marked flaccid tetraparesis
Dates of treatment: February 18-19, 2013

One month after the treatment the patient wrote us the following:

Certainly because of you Easter is better!

I already see some improvements! I see improvements in physical strength and endurance and also some extra movement in the arms!

In a few weeks I should visit a local neurorehabilitation clinic, and I will send you my current neurological picture as soon as I have it!

Thank you so much for all you have done for me! Best wishes for a Happy Easter to all the staff!!!

Jacob D.

Improvement in B.I. condition after stem cell treatment

Patient: B.I.
Gender: Male
Age: 44
Country: Croatia
Diagnosis: ALS, with cervicothoracic involvement, marked tetraparesis, and bulbar palsy.  S.p. disc surgery in 2002. 
Dates of treatment: April 13-14, 2015

Dear EmCell team,

My condition is stable and in remission, which is great. My health condition is in an “invisible mode”, but for this disease it is jack pot. Can I try physical therapy which includes electricity? Please advise, thank you very much.

With best regards,
B.I.

Jacob D.

Feedback on the condition of the patient with Alzheimer’s after the stem cell therapy

Patient: A.F.
Gender: F
Age: 64
Country: Norway
Diagnosis: Alzheimer’s disease. Nodular polyosteoarthrosis of shoulder joints, small wrist joints with grade 0-I functional insufficiency of the joints.
Dates of treatment: February 15-16, 2012

Almost a year after the treatment, we received the following letter on A.F. condition:

Hello,

Thanks for the email. A. has it very good after treatment, she has had great success in all areas. Her doctor tested her for two months and confirmed good results. The doctor was not aware of the treatment she received.The doctor was amazed at the progress.

A. has good appetite, good mood, is more social and active as never before. She takes more initiative and likes to keep fit by cycling, skiing and daily walks. She forgets little now and then, but I do not think this has accelerated. We both believe that the treatment was of great benefit and are thankful for it and your professionalism.

Sincerely,
K. S. F.

Jacob D.

The testimonial of the patient M.N.

Patient M.N.
Age: 42
Gender: Female
Country: USA
Diagnosis: Anti-aging treatment
Date of treatment: December 2011

…I had really bad discoloration areas to my bilateral upper cheek areas on my face. This is almost completely gone. Every morning I see the skin sloughing off my cheeks and literally comes off using my fingertips. It’s amazing! I have been comparing pictures of myself taken three months ago and even two weeks ago, and the results are amazing! I look younger today, than even two weeks ago. This anti-aging is really working. I even got told I look younger now than in the pictures. I was so happy I wanted to do backflips!

The trip to Kiev was a trip of a lifetime. The treatment that we received, ranging from care from the physicians to the drivers taking us to and fro, was just remarkable. The time and effort that is given to each family is well construed and the result is an amazing trip with the most wonderful people in the world. Joseph goes far and beyond to make sure we are all taken care of, and makes sure all our needs are met. All the men and women we met were just absolutely wonderful. To every one of them, I am so very grateful, for all they did for us. Many blessings to each and every one of them.

I am so in love with the people in Kiev, because they are all just beautiful inside and out. That’s how I truly feel. That’s how wonderful this trip really was. To all that participated in our care and health…I am so appreciative.
M.N.

Jacob D.

Feedback from the patients after stem cell therapy

Patient: O.H.
Gender: Female
Age: 13
Country: Denmark
Diagnosis: Developmental delay.  Well-managed secondary hypothyroid
Dates of treatment: May 13-14, 2013 (4th course)

Patient: M.H.
Gender: Female
Age:  50
Country: Denmark
Diagnosis: Chronic fatigue syndrome.  Remission of lumbar osteochondrosis with moderate muscle tone abnormalities.
Dates of treatment: May 13-14, 2013

Three months post-treatment, the patients wrote us the following report on their health condition.

Dear Valentina,

Things have been really good. O.’s OCD – obsessive compulsive behavior – and her anxiety has almost disappeared. Her manual skills has improved, she is now independent pulling up her pants, putting on her shirt and almost independent putting on her socks. She has improved her skills when taking a shower, washing her hair, body, putting conditioner in her hair and so forth.

She has a much more willing attitude to learn new skills and she is now trying to work on the things that are difficult for her. Before she had a very hard time being introduced to things she needed to practice. Also her transitioning has improved, she is smoothly following along and moving on to new activities. Her self-damaging behavior has decreased, she is not hitting herself with the same intensity as before. She is must more calm and cooperative and her compliance has improved in a fantastic way. She is learning new skills and improving very much every week. New sounds and better breathing and she has grown a lot.

In short I would put it this way: it has been the best month in August in all the 10 years I have being doing programs with O. I am so motivated to help her and do the program in contrast to before where is was quite tiresome to do program with O., because she sabotaged the program and was highly oppositional to all things that were introduced to her.

Her prognosis for her heigth was before treatment with stem cells and growth hormone 135 cm. Now the prognosis is 150 cm. And the doctors expect she can get even higher than that.

With regard to me: I have a much better life, more energy, when I do running with O. I am able to do it without getting soar afterwards. I went trough a big court case in August and I was able to focus on O.’s training right after being in the court. So I feel I am better at controlling high stress and getting it out of my system again. I also think my face wrinkles have gotten less and not as deep as before. I look more alive and I feel more alive – and better at cooping with my challenges.

Warmest regards to everybody from O. and M.

EmCell Clinic

EmCell Clinic

Select program for read more

Nowadays, there is no vaccination against SARS-CoV-2, no specific anti-viral therapy for COVID-19 exists.

The focus of this course of therapy using fetal stem cells (FSCs) is a restore for immune and pulmonary systems in patients following exposure to SARS-CoV-2 infection.

After exposure to viral infection, immune system of patients produced specific antibodies against certain strains of virus and supplied definite protection from repeated invasion. However, viral aggression results in exhaustion of all strands of immunity, often with inadequate immune response presented as autoagression that makes human organism susceptible to infecting with the other causative agents and overtime causing appearance of autoimmune diseases.  FSCs quickly regenerate numbers and activity of immunocompetent cells, including reconciled functions of them, reducing autoagression etc.

Therefore, FSCs treatment effects the patient’s immune system in the following ways:

  1. increases blood counts of monocytes and macrophages – resulting in higher phagocytosis – “digestion” of foreign microorganisms or particles.
  2. stimulates auxiliary cells functioning (mast cells, basophiles, eosinophils, platelets) in connective tissues and mucous membranes which participate in regulation of inflammatory reaction. Therapy intensifies secretion of biochemical mediators which participate in protection from infections, and also playing important role in allergy reactions.
  3. enhances activity of natural killers – white blood cells of lymphocytes group which attack and kill infected cells by virus.
  4. increases effectiveness of cellular and humoral immunity by means of higher number of T- and B-lymphocytes.
  5. improves immunology memory – capacity of immune system to react faster and effectively to antigen, the human organism had been preliminarily in contact with.

One of the most severe and remote complications after COVID-19 is a damage of lungs tissue with developing pulmonary fibrosis – pathological overgrowth of connective scar tissue between lungs alveoli and blood vessels, as well as replacement of functional tissues of the lungs with it.

Due to that, oxygen supply to blood vessels is deteriorated, lungs become much rough and breathing is shallow and frequent.

Administration of FSCs contributes to restoration of superficial epithelial layer of alveoli, small blood vessels, helps to inhibit overgrowth of hypertrophic pathological connective tissue, facilitating restoration of gaseous metabolism, production of lung surfactant and capacity to local immune protection etc.

Breathing can gradually recover, breathlessness is reduced in patients, dry cough regresses and physical activity of such affected individuals can be renewed.

We offer both 2 and 3 days course of therapy for such patients, depending on their condition. Established schemes of therapy by use of fetal stem cells maximally restore regenerative potential of human organism.

There are four disorders that fall under the heading of autism spectrum disorder (ASD): autism (also referred to as classical autism), Asperger’s syndrome, childhood disintegrative disorder (CDD), and pervasive developmental disorders (PDD) not otherwise specified.

Stem cell therapy is a novel and effective approach to the treatment of ASDs based on the unique ability of stem cells to influence metabolism and the immune system, and to restore damaged cells and tissues.

The fetal stem cells (FSCs) used by EmCell to treat ASD have a positive impact on all of the body’s organs and systems, starting with the brain. This is extremely important because, with ASD, the brain areas regulating memory, concentration, attention, speech and so on are damaged. Our treatment results in better blood and oxygen flow to the brain, called “improved perfusion,” better replacement of damaged neurons, and better formation of new arteries.

After a certain period, FSCs acquire the properties of the surrounding cells and differentiate into them. This leads to the restoration of white and gray matter and, consequently, to the subsiding of neurological symptoms and to improved intellectual capacity.

As impaired or lost neuron connections are restored, new neuron connections form and brain reactions accelerate because synaptic transmission improves.

Improvements in autistic children that can be expected after stem cell therapy:

  • better tolerance for different foods and improved digestion. Some children begin to try new foods and like them;
  • easier contact with the child, starting with eye contact. Children who did not fix their gaze at objects begin looking at them with interest;
  • more adequate behavior at home and outside;
  • reduced or loss of fear of loud noises, strangers and bright colors. This improvement is gradual;
  • improved verbal skills. If the child was non-verbal, it is very likely to start making sounds, produce syllables and eventually pronounce words. Verbal children are likely to expand their vocabulary;
  • development or improvement of writing skills;
  • improved self-care skills;
  • more sustained attention span and concentration.

Although the degree of these improvements varies from child to child, they have been reported in all cases.

One of the main goals of stem cell therapy is triggering brain development and preparing children for adult life by developing the skills they will need the most: communication, self-care, learning and professional skills.

Stem cell therapy is an effective and safe method for treating autism that can help your children with autism and autism spectrum disorders of different degrees. The earlier treatment is started, the better the results that you can expect.

Stem cell therapy is a very powerful engine, but the best results are reported in combination with proper parental care, diet, educational programs, and other methods (GcMAF, HBOT and so on.)

EmCell specialists can provide detailed and customized post-treatment recommendations.

Testimonials

We have treated with stem cells hundreds of autistic children with success rate of 90%. Below are some parents’ comments about their experience and improvements they see in their children.

As we age, self-renewing capacities of our body naturally decline. This is because stem cell reserves of our body gradually deplete and the ability of stem cells to multiply and replace aging cells with new ones diminishes. Stressful lifestyle, malnutrition, bad habits and poor environment accelerate our body decline. Is there a chance to revert or at least slow down this process?

We offer novel anti-aging therapy using a natural, holistic approach. Our fetal stem cell programs are aimed at both the prevention of premature aging and age-related diseases, and the maintenance of youthfulness.

When introduced into a body that is aging, fetal stem cells expand stem cell reserves and trigger self-renewal processes in all the body’s organs and tissues. They also stimulate the body’s own dormant stem cells, which improves the functioning of the internal organs, boosts the immune system, and increases energy levels. The effects observed in our patients have shown genuine rejuvenation from inside!

By tailoring our treatment to the individual needs of each patient, EmCell ensures the best results from our therapy. Within 26 years, hundreds of patients have undergone anti-aging treatment at EmCell with pronounced improvements reported in 83% of cases, such as:

  • higher energy level, exercise power and capacity to work;
  • firmer and tighter skin, improved hair structure and growth;
  • improved mental capacity, quicker thinking, better memory;
  • subsiding of muscular, joint and back pain, and headaches;
  • normalized functioning of internal organs;
  • boosted immunity;
  • stabilized metabolism, hormone levels and blood pressure;
  • better sleep and the elimination of chronic fatigue;
  • improved libido and sexual functions.

The advantages of our treatment are:

  • lack of side effects;
  • no chemicals involved;
  • minimally invasive procedure (intravenous infusions and subcutaneous injections);
  • no rejection risk;
  • no cancer risk;
  • lifetime follow-up.

Fetal stem cell administration and grafting establish a unique environment where all the body’s cells are stimulated by nature’s most powerful restorative components. Fetal stem cells restore damaged and aging cells, and make the whole body more youthful, something no medication can offer.

Application of fetal stem cell suspensions in rehabilitation period in postinfarction cardiosclerosis and hypertension patients has positive effects on overall health as well as on rheological (flow) properties of blood. These effects have been proved by clinical data of postinfarction and other ischemic heart disease patients followed up at Cell Therapy Center EmCell.

When using fetal cell suspensions containing stem cells, syndrome of early post-treatment improvements is observed in all patients. The major manifestations of this syndrome include decreased weakness, improved overall health and appetite, normalized sleep formula, positive changes in psychoemotional sphere, such as reduced manifestation of somatic depression, improved emotional state, thinking, memory and hope for recovery. 80% of patients report gradual decrease of blood pressure, at first, taking the pre-application dose of antihypertensive drugs, but 2-4 weeks after the stem cell therapy, 45-50% of patients reduce the dose of nitrates and antihypertensive drugs. Also, in all cases observed is gradual decrease and normalization of cholesterol, triglycerides, as well as low and very low density lipoproteins levels. Almost all our patients improve rheological properties of blood that can be related to the increase in prothrombin index and prolongation of coagulation time.

Due to formation of the alternative (additional) systems of collateral vessels in the cardiac muscle, tissue trophism significantly improves, manifestations of ischemia become less expressed, frequency and intensity of angina attacks decrease, and metabolism in myocardium improves.

Improvement in overall health and better ability to work motivate patients to extend their physical activities and return to their working career. All this taken as a whole improves life quality of ischemic heart disease patients and significantly (by 35%) extends their life span.

Within 25 years, we have treated hundreds of patients with cardiovascular diseases who demonstrated different degrees of improvements reported in 87% of cases.

Stem Cell Therapy Center EmCell offers a new, advanced, patented method for diabetes mellitus that has been proved effective in treating 1 and 2 types of diabetes, and in preventing diabetes-related complications, which usually affect the eyes, arteries, kidneys and so on.

In combination with traditional treatment of type 1 diabetes, fetal stem cells (FSC) can help:

  • end the auto-aggression of cell-mediated immunity factors against β-cells;
  • prevent the destruction of β-cells that are functional at the time of the treatment;
  • restore the patient’s own β-cells and improve their functional capacity;
  • prevent diabetes-related complications affecting eyes, kidneys, peripheral nerves, and so on;
  • improve insulin-dependent tissue condition.

In type 2 treatment, fetal stem cells can help:

  • restore peripheral tissue sensitivity to insulin;
  • reduce atherogenic hyperinsulinemia;
  • decrease the production of glucose and pathologic lipids by liver cells;
  • improve the condition of arterial walls, which is vital for the prevention of atherosclerosis and complications arising from it;
  • reduce the dose of hypoglycemic medications.

Within 24 years, EmCell has treated hundreds of patients with both type 1 and type 2 diabetes, with improvements reported in 65% and 74% of cases correspondingly, such as:

  • stabilized carbohydrate metabolism, resulting in more stable blood sugar levels and a gradual decrease of HbA1C;
  • normalized blood counts;
  • longer periods of remission;
  • reduced severity and frequency of diabetes-related complications;
  • higher exercise power;
  • improved sexual capacity;
  • boosted immunity;
  • better overall life quality.

If recommendations are followed and the patient’s lifestyle is healthy, a gradual decrease in hypoglycemic medication doses is also possible.

Diabetes Treatment for Children

Fetal stem cell therapy is one of the most effective treatments for type 1 diabetes mellitus in children and the only one that can slow down or temporarily terminate autoimmune aggression against pancreatic beta cells. If treatment is started within 6-8 weeks after onset, it is possible to prolong “honeymoon” period, sometimes for a long period of time.

In children, fetal stem cell therapy results in:

  • easier and better diabetes management
  • prevention of blood sugar fluctuations (no hyper- and hypoglycaemia that might cause complications at later stages)
  • preservation of beta cell production by the pancreas (if treatment is started early after onset)
  • prevention of serious diabetes-related complication
  • immune boosting
  • better overall health and general development

Stem cell therapy is most effective at the early stages of diabetes. The main criterion for positive effects with diabetes is long-term management of the disease and the inhibition or prevention of complications.

Cell Therapy Center EmCell offers multiple sclerosis (MS) treatment using fetal stem cells, with improvements reported in most cases. The goal of MS treatment is to terminate autoimmune aggression, that is, the internal attack against patient’s own nervous system, by disrupting the main mechanism of the disease. This, in turn, leads to the subsiding or even regression of neurological symptoms.

With MS, fetal stem cells have 2 major functions:

  • prevention of nerve cell damage: Stem cells are able to help reduce or even prevent damage caused to nerve cells.
  • repair of damaged myelin: In MS, the protective myelin layer surrounding nerve fibersis damaged by the person’s own immune system. Specialized stem cells in the brain can generate myelin-producing cells, which facilitates the repair of myelin.

Within 25 years, Cell Therapy Center EmCell has treated hundreds of patients with different forms of MS and achieved improvements in 85% of cases.

After stem cell treatment, our patients report a number of improvements:

  • stabilized condition and the course of the disease alleviated;
  • shorter exacerbation period and longer remissions;
  • less spasticity in the extremities;
  • better gait, coordination and balance;
  • improved speech;
  • psychoemotional and cognitive improvements;
  • boosted immune system;
  • improved functioning in the heart, kidneys, liver and bowel;
  • better quality of life;
  • a chance to return to work if treatment is during the early stages of MS.

Cell Therapy Center EmCell offers stem cell therapy for different types of muscular dystrophy. Fetal stem cells (FCSs) have proved to be one of the options leading not only to reduced muscle wasting but even to some regression in the main symptoms of this disease.

In the course of MD treatment with stem cells, pools of genetically healthy cells are created in the patient’s body. These cell pools are capable of producing dystrophin, which can then penetrate affected cells. Moreover, during the course of determination, differentiation, and morphogenesis, transplanted stem cells produce pools of specialized cells that the patient’s body needs, such as muscular, nervous, endothelial, and so on. Stem cell treatment offers two main kinds of result:

  • production of healthy muscle fibers: Stem cells without the genetic defect that causes MD can be delivered to a patient’s muscles, where they generate working muscle fibers to replace damaged ones.
  • reduced inflammation: In muscular dystrophy, damaged muscles become quite inflamed and this inflammation speeds up muscle degeneration. Stem cells release chemicals that reduce inflammation, slowing the progress of the disease.

MD treatment takes place at different stages of the disease, at different ages, at different levels of muscle atrophy, and at different levels of patient capacity for independent motion—bedridden, in a wheelchair, or able to walk independently.

Fetal stem cells facilitate the synthesis of dystrophin, the deficiency of which causes the disease. Our treatment helps lead to:

  • inhibition of MD progress;
  • prevention of muscle fiber destruction and the preservation of muscle power and bulk;
  • prevention of complications such as respiratory and heart failure;
  • CPK, LDH, ALT and ACT declines indicative of a reduction in muscle destruction;
  • preservation of relative activity and capacity for independent living;
  • boosted immune system;
  • better functioning of internal organs and systems;
  • overall improvement in quality of life.

Within 26 years, EmCell has treated hundreds of patients with different degrees of improvements reported in 88% of cases.

Amyotrophic lateral sclerosis (ALS, Charkot’s disease, Charkot’s sclerosis, in English-speaking countries – Lou Gehrig’s disease), or motor neuron disease, is a progressing illness that manifests as gradual weakening and atrophy of muscles and lasts for two to five years (in very rare cases – for seven years) with 100% fatal outcome. The clinical picture is compliant with lesion of central and peripheral motor neurons that results in bulbar syndrome as well as muscular atrophy in extremities and respiratory muscles.

Major manifestations of amyotrophic lateral sclerosis in patients include the following:

  • weakness;
  • muscle spasms;
  • disorders of speech and swallowing;
  • problems with keeping balance;
  • spasticity;
  • increased deep reflexes, or reflexogenic zone expansion;
  • pathological reflexes;
  • fibrillations;
  • atrophy;
  • hanging foot;
  • respiratory disorders;
  • paroxysms of involuntary laughter or cry;

Treatment of ALS with stem cells

Indications for ALS treatment with stem cells include confirmed ALS diagnosis, disease progression, and lack of response to existing treatment methods. Prior to year 2000, contraindications to treatment included respiratory failure, grade III, artificial lung ventilation, dysphagia, and presence of gastric stoma. However, nowadays Cell Therapy Center EmCell has experience of treating patients with the above-mentioned complications and disorders that allows for prolonging their life by more than five years.

After fetal stem cells therapy, 67% of ALS patients note diminishing weakness, improvement of appetite and mood, decrease in intensity of fasciculations and spasticity. Within two months after treatment, increase of motion volume in extremities, decrease in muscular rigidity, normalization of reflexes, decrease in the number of fasciculation zones, better tolerability of daily chores, reduction in intensity of dysphagia and dysarthria (improvement of swallowing, articulation, and clarity in pronunciation of words) have been observed in 34% of patients. Stable positive clinical effect after treatment persists for three to six months.

About 48% of patients need to repeat the course of treatment during the year for retaining the attained positive results. In 25% of cases, patients need periodic injections of stem cells every 1.5–2 years.

Application of fetal stem cells does not combat the immediate cause of the disease (to date, the exact cause of disease has not been found); however, it exerts substantial influence on links of the pathological process and slows down disease progression. Fetal stem cells therapy improves the quality of life of ALS patients and their ability to work, and prolongs their life.

Treatment of Alzheimer patients with fetal stem cells helps to gradually restore many specific brain functions. Positive results of therapy are observed in all cases. Application of fetal stem cells completely hinders further development of the disease in 75% of patients, or at least substantially slows down progressive deterioration of brain functions.

The most evident and stable effects of treatment (up to 90% cases) are achieved at initial stages of the disease when first neurological and mental symptoms occur. Positive results are also observed in patients with organic brain lesion (atrophy of frontoparietal lobes).

In cases of pronounced mental disorders, treatment effects resolve themselves to improvement of the quality of life (overall condition, sleep, appetite, normalization of body weight).

In patients with Alzheimer disease, two (sometimes three) courses of treatment are recommended during the first year, and then one course in 1–2 years to maintain and enhance the results.

Anemia is a disease related to a decrease in the total amount of red blood cells (erythrocytes) or hemoglobin in the blood that causes decline in the level of oxygen carried from lungs to tissues. Since all human cells require oxygen for life, different degrees of anemia can have a wide range of clinical consequences.

Anemia is the most common blood disorder, affecting about a third of the global population. Three main types of anemia are due to excessive blood loss, increased red blood cell destruction (hemolysis) or impaired red blood cell production (non-effective hematopoiesis).

There are many causes of anemia as well as methods of its treatment. We offer a highly effective fetal stem cell treatment for anemia that addresses and impacts the pathogenetic component of the disease.

Stem cell therapy proved to be effective in treatment of primary and secondary anemia, including aplastic and hereditary anemias. An indication for fetal stem cells administration in patients with an anemic syndrome is lack of response to standard treatment methods.

While pharmacological therapy is mainly aimed at stimulating the patient’s damaged bone marrow, and substitutive blood transfusions address red blood cell deficiency, stem cell therapy focuses on applying cells of erythropoietic series, or erythrocyte precursors, which increases the pool of cells responsible for hematopoies in the patient’s body. The number of erythrocytes and the levels of haemoglobin grow, which leads to significant improvement in patient’s quality of life and reduction in number and dosage of medications taken.  

Positive results of fetal stem cell therapy have been observed in treatment of anemia of various aetiology. They are especially demonstrative in cases of severe aplastic anemia. In all cases, high haemoglobin levels persisted for many years after 1 –2 courses of fetal stem cell treatment. The patients experienced no need for undergoing regular treatment at hospital haematology departments. No other existing methods are capable of yielding such results.

Stem cell therapy for patients with sickle cell anemia helps to reduce the frequency of crises, to soothe their course, as well as decrease the need for repeated transfusions of packed red cells that are associated not only with the well-known risks, but also are very stressful for the patient.

In case of hereditary anemias, stem cell therapy also has many benefits for the patient, but treatment effects decrease with time and successive courses of stem cell treatment are necessary.

According to medical statistics, arterial hypertension, or elevated blood pressure, is the main cause of death all over the world along with cerebral atherosclerosis. EmCell offers fetal stem cell therapy in a combined treatment of arterial hypertension aimed at improving the condition of arterial walls and blood pressure stabilization.

At Cell Therapy Center EmCell, patients with primary arterial hypertension with frequent arterial crises receive fetal stem cells of ectodermal and mesenchymal origin. Stem cells administered into recipient’s body get into the cardiac muscle and produce various biologically active substances, such as growth factors, cytokines, etc., which results in improved heart functioning. Under the influence of the microenvironment, mesenchymal stem cells develop into a phenotype of cardiomyocytes. Pre-neuronal stem cells normalize nervous vascular control resulting in crisis prevention. That is why cell therapy can be used to restore the functional properties of the heart muscle.

Prior to treatment, continuous hypotensive therapy regimen is selected; that allows for preventing hypertensive crises, and diastolic pressure stabilizes at the level no higher than 90 mm Hg.

Stem cell therapy allows to completely restore the integrity of the vascular tissues, their elasticity, conductivity and strength at the biological level. It has the following positive effects in treatment of arterial hypertension:

  • vascular system improvement: stem cells begin to produce angiogenic and anti-inflammatory factors;
  • partial replacement of destroyed or damaged cells;
  • improved cerebral vessel functioning and cardiac blood supply;
  • increased elasticity and permeability of blood vessels;
  • improved delivery of oxygen and nutritional elements to all organs and tissues—brain, heart, liver, kidneys—due to better blood flow.

Within 3–5 months after fetal stem cell therapy, all patients demonstrate stable decline in blood pressure and reduction of hypotensive therapy by approximately 50%.

All patients note positive treatment effects such as disappearance of headache, stabiliziation and normalization of blood pressure and sleep, improved mental ability and sexual potency (both in men and women), return of vivacity – signs of rejuvenation.

Thus, stem cell therapy improves the condition of the vascular system of the human body. Full disclosure of stem cells’ regenerative potential usually occurs within 2-3 months after treatment. To intensify the effects of cell therapy, patients are advised to improve lifestyle, get rid of bad habits, decrease intake of salt and start exercising.

Fetal stem cell treatment is not an alternative to standard protocols of treating cancer. Stem cell therapy is possible only after surgery and/or traditional chemo- and/or radiotherapy, in case they are indicated to the patient.

We accept for treatment patients with stabilized condition proved by results of instrumental and laboratory findings – there should be no primary tumor growth or new metastasis formation.

As conventional cancer treatment has many side effects, stem cell treatment is aimed mainly at:

  • Partial restoration of anti-tumor immunity and haemopoesis;
  • Improvement in patient’s quality of life – reduced weakness, better overall condition, both physical and psycho-emotional.

During the first month after stem cell treatment, our patients may observe the following effects:

  • improved overall condition and appetite;
  • diminished weakness and sweating;
  • increased capacity to work and self-care ability;
  • better emotional status, cognitive abilities and memory.

Within one to two months after fetal stem cells treatment, other positive effects develop (some of them translate into improved laboratory findings), in particular:

  • improved haemopoesis;
  • improved immunological profile;
  • reduced levels of inflammatory markers;
  • higher quality of life.

Fetal stem cell therapy contributes to formation of anti-tumor immunity, which is crucial for preventing relapse and metastatic process. However, stem cell treatment is possible only after traditional treatment.

Our methods have been approved by the Ministry of Health of Ukraine on April 20, 1999 and have been recommended for use in clinical practice.

Cell Therapy Center EmCell offers stem cell therapy for cerebral palsy.

Stem cell therapy has been used for the treatment of cerebral palsy for 25 years, and over the last 4 years EmCell has treated more than 53 children with CP with positive results reported by more than 90% of parents.

The main stem cell treatment results include:

  • replacement of lost brain cells;
  • repair or protection of damaged nerve cells.

Fetal stem cell treatment helps to limit the damage to cells in the brain and makes the symptoms of cerebral palsy more manageable.

A combination of routine methods and stem cell therapy leads to a number of improvements:

  • reduction of hypertonicity in extremities;
  • improved balance;
  • increased mental development, such as patience, interest in external things, concentration, memory, and learning ability;
  • normalized function of internal organs;
  • better social adaptation;
  • easier care for the child.

Stem cell therapy is used to directly augment the regenerative abilities of an injured brain. It opens new opportunities in treating cerebral palsy. The grafted stem cells are able to ameliorate severe injury-related neurological defects.

Stem cell therapy is a very powerful driver, and the best results are reported in combination with physiotherapy and occupational therapy to improve movement and mobility, and speech therapy to improve communication skills.

Cell Therapy Center EmCell offers stem cell treatment for different types of developmental delays.

Developmental delay is the failure of a child to meet certain developmental milestones, such as sitting, walking and talking, at the average age. Developmental delays may indicate a problem in the development of the central nervous system. The child’s mental development is delayed, leading to poor motor and communication skills. Such children catch up to standard development milestones later than normal children.

Our clinic opened 25 years ago and has treated a large number of children from all over the world. Improvements were reported in most cases.

For optimal effect, it is important to start stem cell treatment with your child as early as possible, while the brain is still developing.

Combined treatment involving routine therapy and stem cells results in a number of improvements:

  • cognitive improvements;
  • easier contact with the child, starting with eye contact;
  • improved verbal skills. If the child was non-verbal, it is very likely to start making sounds, produce syllables and eventually pronounce words; verbal children are likely to expand their vocabulary;
  • better learning capacity;
  • improved information processing, such as memory, including memorization and storage, information processing and recall;
  • greater self-confidence. Child feels more protected, less vulnerable, and exposure to the environment does not cause negative emotions;
  • improved social adaptation;
  • better self-care skills;
  • boosted immunity.

The advantages of our method are:

  • lack of side effects;
  • no chemicals involved;
  • minimally invasive procedure (IV infusions and injections);
  • no rejection risk;
  • no cancer risk;
  • lifetime follow-up.

Cell Therapy Center EmCell developed integrated modern method of sexual function improvement and restoration with 83% success rate.

This method is based on correction of hormonal, vascular and neurologic mechanisms of sexual capacity and body regeneration stimulation with fetal stem cells.

Erectile dysfunction is inability to maintain erection sufficient for coitus for 3 months and longer.  It can be caused by both psychological and somatic (urologic, endocrine, vascular and neurologic diseases) factors.  In 50% of cases, both factors are present.

Fetal stem cell therapy results in:

  • psycho-emotional and general health improvement
  • better sleep
  • hormonal balance
  • improvement of artery wall quality and vasomotor tone
  • immune system regulation
  • body regeneration potential stimulation
  • better tissue quality

which ensures optimal condition for sexual activity and libido improvement.

In order to solve the problem in the most effective way, collaboration of the patient and the doctors is needed. Only sincere and straight talk about all the problems will help to adjust our clinical protocol to meet all the patient’s needs.

Diagnostics include:

  • history collection and study
  • filling the forms
  • examination
  • laboratory tests (testosterone, lipid profile, blood sugar etc.)
  • instrumental examination
  • specific examinations

Our diagnostic and treatment program lasts for 5 days (as a rule, Monday-Friday) and includes:

  • Laboratory tests and instrumental examinations.
  • Multidisciplinary case management team meeting for treatment strategy development.
  • Medicinal correction of metabolic, hormonal, vascular, sleep etc. problems.
  • Sexual function stimulation through physical therapy.
  • Administration of fetal cell suspensions.
  • Final recommendations of multidisciplinary case management team.
  • Follow-up after the treatment.

Integrated method of erectile dysfunction treatment results in normal sexual life in 83% of men within 3 months after the treatment.  35% of them do not use additional medications, and 48% use minimal doses of medicines.

Parkinson’s treatment with stem cells

Cell Therapy Center EmCell offers Parkinson’s treatment with fetal stem cells. We have developed schemes of stem cell treatment for management and control of the disease, which has proven to be effective in case of different forms and at all stages of parkinsonism.

At stages I-III, when uni- and bilateral manifestations of the disease are observed, such as balance disturbances, tremor, mild and moderate rigidity, etc., administration of fetal stem cells is effective in 85% of cases. After the treatment, patients report improvement of stiffness, decrease in shaking while walking and tremor. The dose of antiparkinson drugs can be lowered.

At stage IV (severe stiffness, but the patient still can walk or stand unassisted), stem cell treatment is effective in 65-70% of Parkinson’s disease cases. At stage V (bed- or wheelchair-bound), our therapy helps to improve patient’s quality of life and ease care for the patient due to decreased spasticity and tremor syndrome and improved sleep, normalization of organ and system functioning (heart, lungs, bowels).

In 100% of cases, Parkinson’s treatment with fetal stem cells results in psychoemotional improvements. After the stem cell treatment, patients demonstrate positive emotions, improved thinking, more expressive, intelligible and louder speech, and more persistent memory and intellect.

Application of fetal stem cells allows for achieving conspicuous positive results in treatment of rheumatoid arthritis. Indications for fetal stem cell therapy in patients with rheumatoid arthritis are as follows:

  • rheumatoid arthritis resistant to standard treatment;
  • ineffective anti-inflammatory drug therapy, including glucocorticoids and cytostatics;
  • marked decrease in functional capacity of joints;
  • trophic disturbances of the musculoskeletal system (complications of rheumatoid arthritis);
  • considerable deviations of immunologic and hemopoetic parameters.

For treating patients with seropositive, seronegative rheumatoid arthritis of activity grades I–III, with joint functional insufficiency of grades I–III, fetal stem cells of mesodermal, ectodermal, and endodermal origin are used.

As early as within the first days after therapy, the early post-treatemnt improvement syndrome is observed in all patients: diminishing weakness, increased motion activity, normalization of sleep, improved appetite.

Within three months after therapy, inflammatory process activity decreases: morning stiffness, joint tenderness and edema diminish, Ritchie’s index decreases, patients’ functional capacity improves; ESR decreases or returns to normal; C-reactive protein levels and rheumatoid factor titer decline; CD3+, CD8+, and NK lymphocyte count is restored.

In most cases (85%), complete discontinuation or considerable dose reduction of glucocorticoids and non-steroidal inflammatory drugs (NSAIDs) had been achieved. According to X-ray data, no progression of joint damage is observed in 72% of patients.

In 80% patients it was possible to achieve remission along with better quality of life. Remission lasted from six months to three years. Experience shows that clinical remission starts well before improvement of laboratory parameters. In case of unfavourable clinical course of rheumatoid arthritis, repeated injections of fetal stem cells are carried out.

Spinal muscular atrophy (SMA) is a genetically heterogeneous group of hereditary neurologic diseases and one of the types of motor neuron illness. Motor neurons are nervous cells of the spinal cord that set in motion the muscles necessary for executing motor functions of the human body.

The underlying mechanism of this disease is related to progressive degeneration of motor neurons located in anterior horns of the spinal cord, and in some cases – to motor nuclei of the brain stem. Every patient with SMA has a mutation in the survival motor neuron gene, producing a protein that is important for the normal functioning of motor neurons. Absence of this protein leads to atrophy of nervous cells, diminishing of their sizes and death resulting in muscle weakness.

Clinical symptoms of SMA are the following:

  • flaccid paresis and atrophy of striated muscles;
  • fasciculations (more often in adults with disease progression);
  • symmetric lesion of proximal muscles of extremities, less frequently distal amyotrophy, bulbar syndrome, and asymmetric muscle lesion;
  • problems with swallowing and suction in infants;
  • lesion of respiratory muscles that increases proneness to respiratory illnesses (pneumonia and other lung diseases);
  • spine deflection.

We have positive experience of treatment of acquired and genetic diseases affecting spinal motor neurons. Treatment with stem cell allows for attaining remission in 75% of cases, and for diminishing neurogenic dystrophy manifestations in SMA patients in 92% of cases.

We use fetal cell suspensions containing stem cells, in comprehensive treatment of patients with nonspecific ulcerative colitis and Crohn’s disease. Administration of fetal stem cells is effective in cases of both acute and chronic forms of nonspecific inflammatory bowel diseases of all severity grades, including severe course.

Indications for use of fetal stem cells are as follows:

  • progressing disease unresponsive to conservative therapy for 2 weeks;
  • presence of extraenteric complications;
  • impossibility to carry out surgical intervention due to patient’s severe condition resulting from anemia, hypoproteinemia, profound metabolic disorders;
  • exhaustion;
  • difficulty finding the same blood group for transfusion, or same group incompatibility between a donor and a recipient detected through compatibility testing.

The table below presents main clinical criteria of treatment efficacy based on 16 years of experience in patients with nonspecific ulcerative colitis and Crohn’s disease.

After the stem cell treatment, red blood cell count is restored and the haemoglobin level is normalized in patients. Application of fetal stem cells restores immunocompetency and hinders the progression of an autoimmune process (mechanism of development of the illness), allowing to attain prolonged remission. Remission in patients with nonspecific ulcerative colitis lasts, on the average, for 12–15 months, and in patients with Crohn’s disease – for up to 2.5–3 years.

Stem Cell Therapy Center EmCell developed and successfully implemented a new method of improvement and restoration of fertility function in men using fetal stem cells. About 50% of our patients have solved their problems of male infertility.

The usage of stem cell technologies in treatment of infertility in men influences in different causes of this problem, such as blood vessels, hormonal, metabolic problem or inflammation. Using this technology, we can achieve positive effects in those clinical cases, which were non-prospective in view of traditional options of therapy.

After stem cell treatment in EmCell clinic, the following improvements of fertility function might be expected in our patients:

  • Higher amount of sperms in ejaculate, or patients can even start producing sperms in cases with confirmed azoospermia;
  • Better sperms motility;
  • Increase in the amount of morphologically mature (non-defective) sperms in ejaculate;
  • Decrease, or complete elimination of inflammatory changes in ejaculate;
  • Increased duration of relapse-free period in men with inflammation of male reproductive system (compared to traditional therapy);
  • Improvement of erectile function.

Our results in restoration of male fertility consist in increasing amount of “active” sperms in ejaculate during 6 months after fetal stem cells therapy, reported in almost 50% of cases.

35% of patients had successful in vitro fertilization (IVF) and 6% of patients reached fertilization by means of natural sexual intercourse.

The percentage of improvements can vary in each individual case, but positive changes have been reported in all cases. The majority of our patients are men, who did not get experience of any improvement doing the traditional methods of treatment.

Stem cell therapy is a novel and effective approach to the treatment of knee joints arthritis based on the unique ability of stem cells to restore the cartilage and the structure of knee joint.

Stem cells are the source of chondroblasts and chondrocytes, responsible for the formation and restoration of extracellular matrix of cartilage.

Since fetal stem cells show full immune histocompatibility, such therapy helps to achieve quite fast improvements without any kind of immune suppression.

There are three types of knee joints arthritis:

  • Stage 1 – possible spurs, light narrowing of articular cavity.
  • Stage 2 – present spurs, light narrowing of articular cavity.
  • Stage 3 – moderate spurs, possible deformity of the bones, exact narrowing of articular cavity.

After intra articular or para articular injections of fetal stem cells patients can expect for the following improvements, depending on the stage of knee joints damage:

  • Stage 1 – restoration of articular structures because of increased amount of chondrocytes.
  • Stage 2 – Slowing down of degenerative changes, decreasing of pain syndrome and improved the mobility in the joint.
  • Stage 3 – postponing of surgical treatment, slowing down of degenerative changes and elimination of pain syndrome.

Repeated injections of fetal stem cells proved to induce accumulative effect and can maintain the positive results of treatment of the joints.

The most optimal method for the injections is based on the results of X-Ray study. After the procedure each patient is recommended to avoid extensive physical activity. Over 1 week after the injections to the joint, the patient can come back to usual activity of daily life.

The first positive changes can be seen over several days. Such advantages are related to anti-inflammatory properties of biologically active substances, which are the part of stem cell suspension we inject.

The main improvements, caused by increased amount of chondrocytes and much intense formation of extracellular matrix can be seen over 2-3 months.

The results can last for 1-2 years, if each patient follows all recommendations from the treating doctor.

EmCell CLINIQUE — NEW QUALITY OF YOUR LIFE

Medical services:

Post Covid-19
Autism Treatment
Anti-Aging Treatment
Heart Treatment
Diabetes Treatment
Multiple Sclerosis Treatment
Muscular Dystrophy Treatment
ALS/MND
Alzheimer’s Disease
Anemia
Arterial Hypertension

Post-cancer
Cerebral Palsy
Developmental Delay
Erectile Dysfunction
Parkinson’s Treatment
Rheumatoid Arthritis
SMA
Ulcerative Colitis. Crohn’s Disease
Male Infertility
Knee Treatment

The clinic is equipped with an internal reception and a separate entrance to ensure the anonymity of patients. It is guarded around the clock.

The coordinating doctor stays in touch with the patient 24/7 by phone and instant messengers. An interpreter accompanies the patient during their stay in the clinic. We keep in touch even after the patient returns home to receive feedback and continue treatment remotely.

Hospital wards are spacious and comfortable, they resemble rooms in a prestigious hotel. The clinic has a restaurant with a special diet menu. For the period of stay in the country, the patient and accompanying person are provided with a room in the central metropolitan hotel. All transfers to the clinic, to the hotel and to the airport are organized by the clinic at its own expense.

You do not need to search for information, compare prices, book tickets and accommodation, coordinate travel dates with a doctor, hire an interpreter … We take care of all the arrangements for your trip.